BRIEF-Appili Therapeutics Signs Definitive Agreement To Be Acquired By Aditxt Inc

Reuters04-02

April 2 (Reuters) - Appili Therapeutics Inc :

* APPILI THERAPEUTICS SIGNS DEFINITIVE AGREEMENT TO BE ACQUIRED BY ADITXT, INC.

* APPILI THERAPEUTICS INC - SHAREHOLDERS OF APPILI WILL RECEIVE 0.002745004 OF A SHARE OF COMMON STOCK OF ADITXT

* APPILI THERAPEUTICS INC - SHAREHOLDERS OF APPILI WILL ALSO RECEIVE US$0.0467 FOR EACH APPILI SHARE HELD

* APPILI THERAPEUTICS - COMBINED ENTERPRISE EXPECTED TO PROVIDE ENHANCED SYNERGIES AND RESOURCES TO ADVANCE KEY PROGRAMS

* APPILI THERAPEUTICS INC - ARRANGEMENT AGREEMENT ALSO PROVIDES FOR PAYMENT OF A TERMINATION FEE OF CDN$1.25 MILLION IN CERTAIN CIRCUMSTANCES

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2424157670?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-04-02 19:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2424157670","market":"us","top_or_hot":-1,"title":"BRIEF-Appili Therapeutics Signs Definitive Agreement To Be Acquired By Aditxt Inc","media":"Reuters","content":"<html><body><p>April 2 (Reuters) - Appili <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc   :</p><p>   * APPILI THERAPEUTICS SIGNS DEFINITIVE AGREEMENT  TO BE ACQUIRED BY ADITXT, INC.</p><p>   * APPILI THERAPEUTICS INC -  SHAREHOLDERS OF APPILI WILL RECEIVE 0.002745004 OF A SHARE OF COMMON STOCK OF ADITXT</p><p>   * APPILI THERAPEUTICS INC -  SHAREHOLDERS OF APPILI WILL ALSO RECEIVE US$0.0467 FOR EACH APPILI SHARE HELD</p><p>   * APPILI THERAPEUTICS - COMBINED ENTERPRISE EXPECTED TO PROVIDE ENHANCED SYNERGIES AND RESOURCES TO ADVANCE KEY PROGRAMS</p><p>   * APPILI THERAPEUTICS INC - ARRANGEMENT AGREEMENT ALSO PROVIDES FOR PAYMENT OF A TERMINATION FEE OF CDN$1.25 MILLION IN CERTAIN CIRCUMSTANCES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Appili Therapeutics Signs Definitive Agreement To Be Acquired By Aditxt Inc</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Appili Therapeutics Signs Definitive Agreement To Be Acquired By Aditxt Inc\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-04-02 19:55 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>April 2 (Reuters) - Appili Therapeutics Inc   :   * APPILI THERAPEUTICS SIGNS DEFINITIVE AGREEMENT  TO BE ACQUIRED BY ADITXT, INC.   * APPILI THERAPEUTICS INC -  SHAREHOLDERS OF APPILI WILL RECEIVE ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2424157670","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2424157670","pubTimestamp":1712058903,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"April 2 (Reuters) - Appili Therapeutics Inc   :   * APPILI THERAPEUTICS SIGNS DEFINITIVE AGREEMENT  TO BE ACQUIRED BY ADITXT, INC.   * APPILI THERAPEUTICS INC -  SHAREHOLDERS OF APPILI WILL RECEIVE 0.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ADTX":"ADiTx Therapeutics","LENZ":"Therapeutics"},"translate_title":"简介-Appili Therapeutics签署最终协议将被Aditxt Inc。收购","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"ADTX":0.9},"content_text":"April 2 (Reuters) - Appili Therapeutics Inc   :   * APPILI THERAPEUTICS SIGNS DEFINITIVE AGREEMENT  TO BE ACQUIRED BY ADITXT, INC.   * APPILI THERAPEUTICS INC -  SHAREHOLDERS OF APPILI WILL RECEIVE 0.002745004 OF A SHARE OF COMMON STOCK OF ADITXT   * APPILI THERAPEUTICS INC -  SHAREHOLDERS OF APPILI WILL ALSO RECEIVE US$0.0467 FOR EACH APPILI SHARE HELD   * APPILI THERAPEUTICS - COMBINED ENTERPRISE EXPECTED TO PROVIDE ENHANCED SYNERGIES AND RESOURCES TO ADVANCE KEY PROGRAMS   * APPILI THERAPEUTICS INC - ARRANGEMENT AGREEMENT ALSO PROVIDES FOR PAYMENT OF A TERMINATION FEE OF CDN$1.25 MILLION IN CERTAIN CIRCUMSTANCESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.5","shortVersion":"4.22.5","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2424157670"}